Journal
BIOMATERIALS
Volume 301, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2023.122278
Keywords
Focused acoustic vortex; Sonochemotherapy; Immunogenic cell death; Immune checkpoint blockade; Systemic immunity
Ask authors/readers for more resources
This study explored the feasibility of focused acoustic vortex (FAV)-mediated sonochemotherapy combined with immune checkpoint blockade (ICB) to reshape the immunosuppressive tumor microenvironment (TME) and potentiate systemic anti-tumor immunity. FAV-activated sonochemotherapy significantly enriched immunogenic cell death (ICD) inducers in tumors and amplified ICD of cancer cells compared to conventional focused ultrasound (FUS)-activated sonochemotherapy. This research provides a multifunctional strategy for enriching ICD inducers in tumors, amplifying ICD, and improving the immunosuppressive TME to enhance systemic anti-tumor immunity.
Sonodynamic therapy (SDT) as an auxiliary modality of cancer immunotherapy enhances systemic anti-tumor immunity. However, the efficiency of SDT-mediated immunotherapy based on conventional focused ultra-sound (FUS) is restricted by the tiny focal region of FUS. Focused acoustic vortex (FAV) possessing a larger focal region, can induce stronger cavitation and thermal effects than FUS with the same parameters, having the po-tential to overcome this issue. This research investigated the feasibility of FAV-mediated sonochemotherapy combined with the immune checkpoint blockade (ICB) to reshape immunosuppressive tumor microenvironment (TME), inhibit tumor growth and lung metastasis. Sonosensitizer chlorin e6 (Ce6) and chemotherapeutic agent doxorubicin (Dox) were co-loaded into microbubble-liposome complex to compose Ce6/Dox@Lip@MBs (CDLM) for all-in-one synergistic sonochemotherapy, whose main components were clinical approved. FAV-activated CDLM significantly enriched immunogenic cell death (ICD) inducers in tumors and amplified ICD of cancer cells compared with FUS-activated CDLM. Furthermore, the amplified-ICD combined with ICB increased the infiltration of cytotoxic T lymphocytes and natural killer cells, polarized M2 macrophages to M1 macrophages, and decreased regulatory T cells. This study provides a multifunctional strategy for enriching ICD inducers in tumors and amplifying ICD to ameliorate immunosuppressive TME and potentiate systemic anti-tumor immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available